Treatment patterns of FIGO Stage IB2 cervical cancer: A single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy

Oliver Zivanovic, Kaled M. Alektiar, Yukio Sonoda, Qin Zhou, Alexia Iasonos, William P. Tew, John P. Diaz, Dennis S. Chi, Richard R. Barakat, Nadeem R. Abu-Rustum

Research output: Contribution to journalArticle

31 Scopus citations

Abstract

Objective: The treatment of FIGO stage IB2 cervical cancer is controversial. Our aim was to assess treatment patterns, outcomes, and complications in patients with stage IB2 cervical cancer. Methods: A retrospective study of patients with stage IB2 cervical carcinoma at a single institution between January 1982 and September 2006 was performed. To adequately control treatment variables, we only included patients who underwent their entire treatment at our institution. Toxicity was assessed using NCI Common Toxicity Criteria (CTC). Results: We identified 82 patients, of whom 47 met the strict inclusion criteria. Of these, 27 patients (57%) underwent primary radical hysterectomy (RH) and 20 (43%) were treated with definitive radiation/chemoradiation therapy (RT/CRT). Patients selected for RT/CRT had a higher American Society of Anesthesiologist (ASA) score than those selected for surgery (P = 0.037). The 3-year progression free survival rate was 52% for the RH group and 55% for the RT/CRT group (P = 0.977). The 3-year overall survival rates were 72% and 55%, respectively (P = 0.161). Overall, 52% of patients in the RH group received postoperative radiation therapy as part of their adjuvant treatment. CTC grade 3, 4, and 5 complications affected 5 patients (19%) in the RH group and 3 (15%) in the RT/CRT group. Conclusion: Both RH and definitive RT/CRT are adequate management strategies for patients with FIGO stage IB2 cervical cancer. However, there was a subset of patients in whom RH as monotherapy was appropriate. Further studies are needed to evaluate the role of new preoperative models that will accurately identify these patients.

Original languageEnglish (US)
Pages (from-to)265-270
Number of pages6
JournalGynecologic oncology
Volume111
Issue number2
DOIs
StatePublished - Nov 1 2008

Keywords

  • Chemoradiation therapy
  • FIGO stage IB2 cervical carcinoma
  • Radical hysterectomy

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Fingerprint Dive into the research topics of 'Treatment patterns of FIGO Stage IB2 cervical cancer: A single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy'. Together they form a unique fingerprint.

  • Cite this

    Zivanovic, O., Alektiar, K. M., Sonoda, Y., Zhou, Q., Iasonos, A., Tew, W. P., Diaz, J. P., Chi, D. S., Barakat, R. R., & Abu-Rustum, N. R. (2008). Treatment patterns of FIGO Stage IB2 cervical cancer: A single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy. Gynecologic oncology, 111(2), 265-270. https://doi.org/10.1016/j.ygyno.2008.07.050